Leukocyte L1 Antigen Complex (Calgranulin)

Subscribe to Selected New Research on Leukocyte L1 Antigen Complex

297 relevant articles (11 outcomes, 47 trials/studies) found for this Bio-Agent

Description: A member of the S-100 protein family that is present at high levels in the blood and interstitial fluid in several infectious, inflammatory, and malignant disorders, including rheumatoid arthritis, inflammatory bowel disease, and cystic fibrosis. It is a complex of a light chain (CALGRANULIN A) and a heavy chain (CALGRANULIN B). L1 binds calcium through an EF-hand motif, and has been shown to possess antimicrobial activity.

Also Known As:

Calgranulin; 27E10 Antigen; Calcium-Binding Myeloid Protein P8,14; Calprotectin; Migratory Inhibitory Factor-Related Protein MRP; Myelomonocytic Antigen L1; Antigen L1, Myelomonocytic; Antigen, 27E10; Antigen, L1; Calcium Binding Myeloid Protein P8,14; L1 Protein, Leukocyte; Migratory Inhibitory Factor Related Protein MRP; L1 Antigen; Leukocyte L1 Protein

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins

Proteins: 56522

Carrier Proteins: 7370

Calcium-Binding Proteins: 198

S100 Proteins: 1945

Leukocyte L1 Antigen Complex: 297

Calgranulin A: 33

Calgranulin B: 24

Nerve Tissue Proteins: 2

S100 Proteins: 1945

Leukocyte L1 Antigen Complex: 297

Calgranulin A: 33

Calgranulin B: 24

Biological Factors: 868

Antigens: 93142

Surface Antigens: 3823

Leukocyte L1 Antigen Complex: 297

Calgranulin A: 33

Calgranulin B: 24

Experts

1.	Fagerhol, Magne K: 7 articles (04/2008 - 08/2002)
2.	Kolho, Kaija-Leena: 3 articles (10/2008 - 06/2006)
3.	Savilahti, Erkki: 3 articles (10/2008 - 06/2006)
4.	D'Incà, Renata: 3 articles (08/2008 - 04/2007)
5.	Staff, Anne Cathrine: 3 articles (04/2008 - 02/2005)
6.	Hellström, Per M: 3 articles (10/2007 - 02/2005)
7.	Bjarnason, I: 3 articles (09/2001 - 02/2000)
8.	Tøn, H: 3 articles (09/2001 - 01/2001)
9.	Sipponen, Taina: 2 articles (10/2008 - 01/2008)
10.	Nuutinen, Hannu: 2 articles (10/2008 - 01/2008)

Related Diseases

1.	Inflammation 04/01/2006 - "Calprotectin may modify the clearance of spirochetes at sites of inflammation." 10/01/2003 - "Fecal calprotectin can be used as a marker of gastrointestinal inflammation, and an improved assay has recently been developed" 04/01/2005 - "The aim of this study was to evaluate the use of fecal calprotectin to detect colorectal inflammation in children with gastrointestinal symptoms" 04/01/2003 - "The aim of this study was to evaluate the effect of intervention with probiotics on ileal pouch inflammation and perfusion in the pouch, assessed by endoscopy, histology, fecal calprotectin and LDF" 02/01/2000 - "This study was designed to compare single and 24-hour stool measurements of calprotectin in patients with and without evidence of ileal pouch inflammation with endoscopic, histologic, and immunohistochemical indices" Get all the results and reference details, order at left...
2.	Crohn Disease (Crohn's Disease) 05/01/2004 - "Calprotectin concentration was significantly greater in patients with Crohn's disease compared with controls (n = 25, P <0.001) and patients with IBS (n = 25, P <0.001)" 01/01/2006 - "The aim of this study was to prospectively evaluate the role of calprotectin as a predictive marker for one year post-surgical endoscopic recurrence in comparison with ultrasound in patients with asymptomatic Crohn's disease" 01/01/2006 - "However, no data regarding the role of calprotectin in predicting post-surgical recurrence in asymptomatic Crohn's disease are available" 01/01/2006 - "The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn's disease: a comparison with ultrasound." 06/01/2005 - "Faecal calprotectin in the assessment of Crohn's disease activity." Get all the results and reference details, order at left...
3.	Neoplasms (Cancer) 04/01/2008 - "OBJECTIVE: Recent studies indicate that circulating calprotectin may serve as a biomarker in some cancers" 10/01/2007 - "The results of cell proliferation analysis revealed that human calprotectin initiated growth inhibition of the tumor cells in a dose-dependent manner" 10/01/2003 - "Neither tumor number (p = 0.85) nor tumor size (p = 0.86) significantly influenced the observed fecal calprotectin concentrations" 03/01/2001 - "Calprotectin levels were significantly decreased 3 months after cancer removal" 02/01/2001 - "Median calprotectin concentration did not differ significantly between different tumor stages, although the levels were slightly lower in Dukes stage A tumor than in the rest of the stages" Get all the results and reference details, order at left...
4.	Ulcerative Colitis 01/07/2008 - "AIM: To investigate possibility and clinical application of fecal calprotectin in determining disease activity of ulcerative colitis (UC)" 01/07/2008 - "Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis." 01/01/2007 - "Our aim was to evaluate fecal calprotectin concentrations (FCCs) in first-degree relatives of patients with ulcerative colitis (UC)" 01/01/2007 - "Fecal calprotectin in first-degree relatives of patients with ulcerative colitis." 05/01/2005 - "Calprotectin: a predictive marker of a relapse in ulcerative colitis." Get all the results and reference details, order at left...
5.	Calculi (Calculus) 05/01/1996 - "In human tissues, all of osteopontin, calprotectin, macrophage exhibited positive results in the renal distal tubular cells and in the calculus nucleus in the renal distal tubular cavity" 05/01/1997 - "After fixation and demineralization of dental calculi adhered to tooth roots, sections embedded in paraffin were immunoreacted with the antibody for calprotectin and positive immunostaining for calprotectin was observed" 05/01/1996 - "In this study, the organic substances playing an important role in the formation of calculus, such as osteopontin, calprotectin, macrophage and cytokines, are investigated for their significance in the calculus formation mechanism" 05/01/1996 - "Subsequently, in the renal distal tubular cells stimulated with macrophage and cytokines, the expression of osteopontin and calprotectin takes place, and these organic substances bind to calcium, whereby forming the calculus nucleus." Get all the results and reference details, order at left...
137 Diseases and 297 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Lactoferrin
2.	Osteopontin
3.	avridine
4.	C-Reactive Protein
5.	Biological Markers (Surrogate Marker)
6.	Calcium
7.	Zinc
8.	Antigens
9.	zinc-binding protein (zinc binding protein)
10.	Leukocyte Elastase (Neutrophil Elastase)
122 Drugs and Important Bio-Agents and 144 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Colonic Pouches (S Pouch)
2.	Homologous Transplantation (Allograft)
3.	Thoracotomy
4.	Plasma Exchange
5.	Nephrectomy
8 Therapies and Procedures and 5 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>